Research field (3)：
Genomics
, Hematology and oncology
, Other
Research keywords (4)：
造血器腫瘍
, ゲノム解析
, 遺伝子診断
, 遺伝子検査
Research theme for competitive and other funds (4)：
2019 - 2022 急性骨髄性白血病と非腫瘍性血液疾患のクローン性造血についての遺伝子変異解析
2016 - 2019 Relationship between NfkB signaling and epigeneteic signaling in malignant lymphoma.
2015 - 2019 The relationship BCR signaling pathway and functional variants of TNFAIP3/A20
2013 - 2016 Relationship of NFkB signaling and surrounding T cell co-inhibitory signaling in malignant lymphoma.
Papers (33)：
Tomotaka Suzuki, Dai Maruyama, Akiko Miyagi-Maeshima, Junko Nomoto, Kinuko Tajima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Suguru Fukuhara, et al. Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy. Cancer medicine. 2021. 10. 15. 5101-5109
Tomotaka Suzuki, Suguru Fukuhara, Junko Nomoto, Satoshi Yamashita, Akiko M Maeshima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Wataru Munakata, et al. Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors. Haematologica. 2021. 106. 2. 593-596
Suzuki Tomotaka, Fukuhara Suguru, Nomoto Junko, Yamashita Satoshi, Maeshima Akiko Miyagi, Ito Yuta, Hatta Shunsuke, Yuda Sayako, Makita Shinichi, Munakata Wataru, et al. Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing. BLOOD. 2018. 132
